InvestorsHub Logo
Followers 22
Posts 891
Boards Moderated 0
Alias Born 01/09/2014

Re: None

Thursday, 07/09/2015 12:28:55 PM

Thursday, July 09, 2015 12:28:55 PM

Post# of 462960
I see the Phase 2a study is being conducted overseas. Why Australia?

Phase 2a Study of ANAVEX2-73 Adaptive-Trial-Design With Repeated Doses, MTD Finding, Pharmacodynamic and Bioavailability Evaluation in Patients With Mild to Moderate Alzheimer's Disease With a 6-Month Open Label Follow-Up Period

https://clinicaltrials.gov/ct2/show/NCT02244541?term=ANAVEX+2-73&rank=1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News